Metabolic Syndrome and Neurological Disorders 2013
DOI: 10.1002/9781118395318.ch12
|View full text |Cite
|
Sign up to set email alerts
|

Alterations in the Endocannabinoid System as a Link Between Unbalanced Energy Homeostasis, Neuroinflammation, and Neurological and Neuropsychiatric Disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 102 publications
0
3
0
Order By: Relevance
“…The endocannabinoid system (ECS) has involvement in the signaling network of physiological processes in both the central nervous system (CNS) and peripheral tissues and thus, plays an important role in disorders of the CNS [1], in the immune system [2,3], in energy homeostasis [4], in inflammatory pain [5] and in the cardiovascular system of mammals [6]. The ECS consists of the endocannabinoids, type-1 and type-2 G protein-coupled cannabinoid receptors (i.e., CB 1 and CB 2 ), transporters, and enzymes that tightly regulate biosynthesis and degradation of endocannabinoids ( Figure 1) [3,7,8].…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…The endocannabinoid system (ECS) has involvement in the signaling network of physiological processes in both the central nervous system (CNS) and peripheral tissues and thus, plays an important role in disorders of the CNS [1], in the immune system [2,3], in energy homeostasis [4], in inflammatory pain [5] and in the cardiovascular system of mammals [6]. The ECS consists of the endocannabinoids, type-1 and type-2 G protein-coupled cannabinoid receptors (i.e., CB 1 and CB 2 ), transporters, and enzymes that tightly regulate biosynthesis and degradation of endocannabinoids ( Figure 1) [3,7,8].…”
Section: Introductionmentioning
confidence: 99%
“…The balance between AEA and 2-AG biosynthesis and inactivation determines their accumulation in tissues and thus, their biological activity. Therefore, for the past decade, the modulation of AEA and 2-AG levels in biological fluids and tissues through the binding of small molecule inhibitors to FAAH and MAGL enzymes has been a therapeutic strategy for a number of diseases including pain, schizophrenia, stroke, obesity, Alzheimer's disease, multiple sclerosis, and cancer, to name just a few [1][2][3][4][5][6][23][24][25]. Several small molecule reversible and irreversible inhibitors for FAAH and MAGL have been discovered with the numbers of selective FAAH inhibitors exceeding those of MAGL inhibitors [26][27][28][29].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation